Literature DB >> 18957649

Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits.

Tonie E Rocke1, Susan R Smith, Dan T Stinchcomb, Jorge E Osorio.   

Abstract

Prairie dogs (Cynomys spp.) are highly susceptible to Yersinia pestis and, along with other wild rodents, are significant reservoirs of plague for other wildlife and humans in the western United States. A recombinant raccoon poxvirus, expressing the F1 antigen of Y. pestis, was incorporated into a palatable bait and offered to three groups (n = 18, 19, and 20) of black-tailed prairie dogs (Cynomys ludovicianus) for voluntary consumption, either one, two, or three times, at roughly 3-wk intervals. A control group (n = 19) received baits containing raccoon poxvirus without the inserted antigen. Mean antibody titers to Y. pestis F1 antigen increased significantly in all groups ingesting the vaccine-laden baits, whereas the control group remained negative. Upon challenge with virulent Y. pestis, immunized groups had higher survival rates (38%) than the unimmunized control group (11%). The mean survival time of groups ingesting vaccine-laden baits either two or three times was significantly higher than that of animals ingesting vaccine-laden baits just one time and of animals in the control group. These results show that oral immunization of prairie dogs against plague provides some protection against challenge at dosages that simulate simultaneous delivery of the plague bacterium by numerous (3-10) flea bites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957649     DOI: 10.7589/0090-3558-44.4.930

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  22 in total

Review 1.  Developing live vaccines against plague.

Authors:  Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  J Infect Dev Ctries       Date:  2011-09-14       Impact factor: 0.968

2.  Resistance to plague among black-tailed prairie dog populations.

Authors:  Tonie E Rocke; Judy Williamson; Kacy R Cobble; Joseph D Busch; Michael F Antolin; David M Wagner
Journal:  Vector Borne Zoonotic Dis       Date:  2011-09-16       Impact factor: 2.133

Review 3.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Plague outbreaks in prairie dog populations explained by percolation thresholds of alternate host abundance.

Authors:  Daniel J Salkeld; Marcel Salathé; Paul Stapp; James Holland Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

5.  Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.

Authors:  Joseph N Brewoo; Tim D Powell; Dan T Stinchcomb; Jorge E Osorio
Journal:  Vaccine       Date:  2010-07-12       Impact factor: 3.641

Review 6.  Protecting against plague: towards a next-generation vaccine.

Authors:  E D Williamson; P C F Oyston
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

7.  Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums.

Authors:  D M Tompkins; D S L Ramsey; M L Cross; F E Aldwell; G W de Lisle; B M Buddle
Journal:  Proc Biol Sci       Date:  2009-06-03       Impact factor: 5.349

8.  Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.

Authors:  Laura Evgin; Markus Vähä-Koskela; Julia Rintoul; Theresa Falls; Fabrice Le Boeuf; John W Barrett; John C Bell; Marianne M Stanford
Journal:  Mol Ther       Date:  2010-02-16       Impact factor: 11.454

9.  Age at Vaccination May Influence Response to Sylvatic Plague Vaccine (SPV) in Gunnison's Prairie Dogs (Cynomys gunnisoni).

Authors:  Tonie E Rocke; Dan Tripp; Faye Lorenzsonn; Elizabeth Falendysz; Susan Smith; Judy Williamson; Rachel Abbott
Journal:  Ecohealth       Date:  2015-01-15       Impact factor: 4.464

10.  Identification of small-molecule inhibitors of Yersinia pestis Type III secretion system YscN ATPase.

Authors:  Wieslaw Swietnicki; Daniel Carmany; Michael Retford; Mark Guelta; Russell Dorsey; Joel Bozue; Michael S Lee; Mark A Olson
Journal:  PLoS One       Date:  2011-05-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.